De Oro’s core product, the NexStride, is a self-contained, attachable gadget that provides two external cues — a metronome-like ding and a laser-projected line — to trigger alternate neural pathways and reduce freezing in people with Parkinson’s. The unit mounts to a walker or cane with a stretchy loop and includes a corded controller and hardware dials to set volume, tempo, and laser position. The company chose a manual operation model after user and clinician feedback, and customer polls and clinical referrals indicate improved confidence and mobility among users. NexStride competes with devices like the U-Step but differentiates on portability and the ability to attach to users’ preferred mobility aids; De Oro keeps manufacturing in the U.S., which raises costs. The retail price is $500 and is not yet broadly covered by insurance, though veterans can obtain units through the VA and the Parkinson’s Wellness Fund may cover partial or full costs for some buyers. De Oro plans to use recent funding to scale operations and expand distribution so more people can access the device.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2022